Development of Foam Drying and Application to Novel Modalities

Promising novel therapeutics, such as cellular and gene therapies, present new challenges to the development of stable, dried biopharmaceutical products. Recent work has evaluated the stability of foam dried preparations and data will be presented highlighting the role of drying method, formulation composition, and drying process parameters on product quality. Challenges to the implementation of foam drying in development will be discussed including the role of formulation and process design in addressing these challenges. While foam drying is still early in development, it has unique benefits that may be applied to drying new biologic modalities. Presented by Bryan Balthazor Scientist at Pfizer Inc.